Case study of a critically ill person with COVID-19 on ECMO successfully treated with leronlimab
The number of confirmed cases of infection with SARS-CoV-2, the virus causing Coronavirus disease 2019 (COVID-19), continues to increase and is associated with substantial morbidity and mortality in virtually every country in the world. Although in the long-term mass vaccinations remains the most pr...
Main Authors: | Sohier Elneil, Jacob P. Lalezari, Nader Z. Pourhassan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | Journal of Translational Autoimmunity |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589909021000174 |
Similar Items
-
Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab
by: Nicholas Agresti, et al.
Published: (2021-01-01) -
Cannulation in ECMO
by: Indira Jayakumar
Published: (2017-01-01) -
Intracerebral hemorrhage associated COVID-19 patient with normal coagulation profile after ECMO treatment: A case report
by: Wael Osman Amer, et al.
Published: (2023-06-01) -
Femoral shaft fracture osteosynthesis in a critically ill patient under Extracorporeal Membrane Oxygenation (ECMO)
by: Calvo Cristobal, et al.
Published: (2016-01-01) -
Electron Microscopic Confirmation of Anisotropic Pore Characteristics for ECMO Membranes Theoretically Validating the Risk of SARS-CoV-2 Permeation
by: Makoto Fukuda, et al.
Published: (2021-07-01)